During the meeting with the Director-General of Licensing at the Iraqi Ministry of Health, discussions were held regarding the registration of medical products such as "MMR" and polio vaccines, as well as the export process of antivenin serums to Iraq. The Ministry of Health in Iraq extended the registration of Razi Institute products until 2029 based on their unique quality.

Dr. Es-haghi emphasized Iraq's interest in utilizing biological products and derivatives from neighboring countries, particularly Iran. The therapeutic serums produced by the Razi Institute are in high demand in Iraq and have gained significant popularity among the population.